Doxazosin for the symptomatic treatment of benign prostatic hyperplasia

Affiliations

¹ Department of Urology, Feinberg School of Medicine, Northwestern University, Tarry Building Room 11-715, 303 East Chicago Avenue, Chicago, IL 60611-3008, USA. k-mcvary@northwestern.edu

Comment

Kevin T McVary. Curr Urol Rep. 2003 Aug.

. 2003 Aug;4(4):267-8.

doi: 10.1007/s11934-003-0082-3.

¹ Department of Urology, Feinberg School of Medicine, Northwestern University, Tarry Building Room 11-715, 303 East Chicago Avenue, Chicago, IL 60611-3008, USA. k-mcvary@northwestern.edu

No abstract available

Comment on

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial.
Kirby RS, Roehrborn C, Boyle P, Bartsch G, Jardin A, Cary MM, Sweeney M, Grossman EB; Prospective European Doxazosin and Combination Therapy Study Investigators. Kirby RS, et al. Urology. 2003 Jan;61(1):119-26. doi: 10.1016/s0090-4295(02)02114-3. Urology. 2003. PMID: 12559281 Clinical Trial.